Partial-onsent (Focal) Seizures Treatment Study

I'm Interested!

Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-onset (Focal) Seizures

Sex at Birth: Any
Age: Child (Birth - 17)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase III
Conditions Being Studied: Epilepsy

Study Purpose

We are doing this study to see if Cenobamate helps reduce or stop partial onset seizures (POS) and see how safe it is for children taking it as a long term treatment.

Principal Investigator
Jennifer Waldron DO

Department/Division
Pediatrics (Neurology)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: STUDY20221340
StudyID: 2022-01093
ClinicalTrials.gov: NCT05067634

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422